Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
major depressive disorder, Spravato
FDA approves Spravato, first monotherapy nasal spray to treat depression
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato was approved to treat a major depressive disorder,
FDA Clears Spravato For Monotherapy Depression Treatments
The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of depression, officials said. The FDA granted approval to Spravato (esketamine) as the first monotherapy for adults with treatment-resistant depression,
J&J’s Spravato receives FDA label expansion for depression monotherapy
Johnson & Johnson’s (J&J) nasal spray Spravato (esketamine) has received a label expansion, now approved as a monotherapy treatment for major depressive disorder (MDD) in adults who do not respond to two oral antidepressants.
3h
on MSN
FDA Approves Nasal Spray for Depression
The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...
21h
J&J's Spravato Wins FDA Approval, Stands as a Game-Changer for Mental Health Care
New Brunswick, NJ January 21, 2025 Johnson & Johnson ( NYSE:JNJ) has finally got its breakthrough depression treatment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Prince Harry settles suit
Los Angeles wildfire updates
California fires: How to help
Soda button reinstalled
Murder charge upheld
Faces new allegations
Turns down plea deal
The Band's keyboardist dies
Meta ex-COO sanctioned
Files $500M defamation suit
Bryan pastor found guilty
Can target schools, churches
Silk Road founder pardoned
1st Japanese elected to HOF
Voice of Navy football dies
Wildfires near San Diego
Raising prices again
SCOTUS grants new hearing
FDA approves nasal spray
'Days of Our Lives' star dies
Doug Collins hearing
Antisemitism lawsuits settled
Discuss strengthening ties
Birthright citizenship suit
Trailblazing cartoonist dies
Released from prison
Israel’s top general resigns
Coast Guard chief fired
Feedback